The first Marvel insider added that Sabra's comic backstory was always going to be updated in "Captain America 4," and her ...

Marvel will also not be using the name Sabra in the film, according to the Hollywood Reporter. The announcement of Bat-Seraph ...

While the response to most MCU projects of late has been underwhelming, to say the least, fans are still waiting eagerly for ...

Here's every upcoming Marvel movie and TV show coming to the ... Shira Haas makes her MCU debut as the superhero Sabra and Giancarlo Esposito will appear as the villain Sidewinder, leader of ...

Marvel Enterainment, a subsidiary of Disney, is under fire for erasing the Israeli heritage of longtime Jewish superhero Sabra ahead of her appearance in a new movie.

Marvel first announced Captain America 4‘s ... Shira Haas will join the film as Sabra. Xosha Roquemore has joined the movie in an unknown role, and WWE wrestler Seth Rollins was spotted in ...

Brave New World star Tim Blake Nelson opens up about coming back as The Leader and why he's glad his return happened now.

Marvel Studios' latest movie ... Shira Haas will play the superheroine Sabra, while Danny Ramirez and Carl Lumbly will reprise their roles from "The Falcon and the Winter Soldier." ...

Not even Thanos' snap could stop the Marvel Cinematic Universe (MCU). With new movies and shows pouring in, what better way to get fully caught up than by binge-watching everything released so far?

Wells Fargo analyst James Feldman maintained a Hold rating on Sabra Healthcare REIT (SBRA – Research Report) today and set a price target of $16.00. The company’s shares opened today at $16.28.

Analyst Juan C. Sanabria of BMO Capital maintained a Hold rating on Sabra Healthcare REIT (SBRA – Research Report), boosting the price target to $17.50. Juan C. Sanabria has given his Hold ...

For the quarter ended June 2024, Sabra Healthcare (SBRA) reported revenue of $176.14 million, up 9.3% over the same period last year. EPS came in at $0.36, compared to $0.09 in the year-ago quarter.